PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice.
Kordala AJ. et al, (2023), EMBO Mol Med, 15
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1.
Stoodley J. et al, (2023), Int J Mol Sci, 24
Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy.
Stoodley J. et al, (2023), Methods Mol Biol, 2587, 209 - 237
Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy.
Hammond SM. et al, (2022), JCI Insight, 7
Evaluating Efficacy of Peptide-Delivered Oligonucleotides Using the Severe Taiwanese SMA Mouse Model.
Goli L. et al, (2022), 2383, 491 - 513
Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization.
Hammond SM. et al, (2021), Nucleic Acid Ther, 31, 190 - 200